Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

Trial Profile

Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

Phase of Trial: Phase IV

Latest Information Update: 15 Jan 2010

At a glance

  • Drugs Pravastatin (Primary) ; Simvastatin (Primary)
  • Indications Alzheimer's disease; Hypercholesterolaemia
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 06 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top